InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Luke Thomas Charles, Directeur Médical. Director active across 1 company, notably SAB Biotherapeutics, Inc.. In total, 1 filings have been logged. History available since 19 October 2021. The latest transaction was disclosed on 19 October 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations1 total
990 shares@ US$10.1050.0% of flowCommon StockSEC:0001493152-21-026388:0
1 of 1 declaration
About Luke Thomas Charles
Thomas Charles Luke serves as Chief Medical Officer at SAB Biotherapeutics, Inc. In this role, he is responsible for leading the company's medical initiatives and clinical research. His medical expertise allows him to oversee the development of new treatments and ensure compliance with regulatory standards. He plays a key role in healthcare innovation and improvement.
